Engineering polycotton fiber surfaces, with an timicrobial activity against S. aureus, E. Coli, C. albicans and SARS-CoV-2
![Thumbnail](/xmlui/bitstream/handle/10234/192518/andres_2020_engineering.pdf.jpg?sequence=5&isAllowed=y)
View/ Open
Impact
![Google Scholar](/xmlui/themes/Mirage2/images/uji/logo_google.png)
![Microsoft Academico](/xmlui/themes/Mirage2/images/uji/logo_microsoft.png)
Metadata
Show full item recordcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/7013
comunitat-uji-handle3:10234/8638
comunitat-uji-handle4:
INVESTIGACIONMetadata
Title
Engineering polycotton fiber surfaces, with an timicrobial activity against S. aureus, E. Coli, C. albicans and SARS-CoV-2Author (s)
Date
2020-12-20Publisher
ScieniQ PublishersISSN
1000-1000Bibliographic citation
TREMILIOSI, Guilherme C., et al. Japan Journal of Medical Science. Japan Journal of Medical Science, 2020, vol. 1, no 4, p. 47.Type
info:eu-repo/semantics/articlePublisher version
http://www.scieniqpublishers.com/japan-journal-of-medical-science/Version
info:eu-repo/semantics/publishedVersionSubject
Abstract
Pathogenic microorganisms are becoming a potential threat to the health of human beings and the environment worldwide. In this present study, we
have developed a polycotton fiber, in which by incorporation and ... [+]
Pathogenic microorganisms are becoming a potential threat to the health of human beings and the environment worldwide. In this present study, we
have developed a polycotton fiber, in which by incorporation and functionalization of aggregated Ag NPs are achieved by using the pad-dry-cure meth- od. Upon contact, this coating shows antimicrobial activity against S. aureus, E. Coli, C. albicans and SARS-CoV-2. The polycotton AgNP, inhibiting
nearly of the virus was able to prevent cross-infections, and does not causes allergies or photoirritation, proving the safety of its use. To the best of our
knowledge, this is the first report of an antimicrobial coating that could rapidly reduce the infective load of bacteria, fungi, and inhibit SARS--CoV-2.
Taken together, the antimicrobial coating reported herein holds great promise to be developed for further application in healthcare settings. [-]
Funder Name
Brazilian research financing institutions: Fundação de Amparo à Pesquisa do Estado de São Paulo | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | d Financiadora de Estudos e Projetos (FINEP) | Universitat Jaume I | Ministerio de Ciencia, Innovación y Universidades (Spain)
Project code
FAPESP CEPID-finance code 2013/07296-2 | Process 2017/24769- 2 | Process 2016/20045-7 | Process 2018/04609-3 | PIPE-finance codes 2004/08778-1 and 2017/15924-4 | Finance Code 001 | UJI-B2016-25 | UJI-B2019-30 | PGC2018-094417- B-I00
Rights
© 2020 Elson Longo
OPEN ACCESS
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/openAccess
This item appears in the folowing collection(s)
- QFA_Articles [826]
The following license files are associated with this item: